INAVA promotes aggressiveness of papillary thyroid cancer by upregulating MMP9 expression

INAVA promotes aggressiveness of papillary thyroid cancer by upregulating MMP9 expression

Abstract Background Innate immunity activator (INAVA) has been shown to be elevated in lung adenocarcinoma. However, its expression pattern and function in papillary thyroid cancer (PTC) are unknown. This study aimed to identify the clinical, biological, and mechanistic impacts of INAVA on PTC. Meth...

Full description

Bibliographic Details
Main Authors: Hongyu Guan, Yan Guo, Liehua Liu, Runyi Ye, Weiwei Liang, Hai Li, Haipeng Xiao, Yanbing Li
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Cell & Bioscience
Subjects:
INAVA
Papillary thyroid cancer
Invasion
MMP9
FGF1
Online Access:http://link.springer.com/article/10.1186/s13578-018-0224-4

Internet

http://link.springer.com/article/10.1186/s13578-018-0224-4

Similar Items